Integrative Genomic Analysis for the Identification of Disease-Associated Variants and Therapeutic Targets
Indus Journal of Bioscience Research · 30.03.2026 · 4 (3) · 145-152
DOI: 10.70749/ijbr.v4i3.3036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indus Journal of Bioscience Research, online erschienen am 30.03.2026. Verfasst von Sajid Hussain und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Integrative genomic approaches have emerged as powerful tools for understanding the molecular basis of complex diseases by combining multi-omics datasets. In this study, we performed a comprehensive integrative analysis to identify disease-associated genetic variants and prioritize potential therapeutic targets. Genome-wide association and sequencing data analysis identified 1,248 significant loci (p < 5 × 10⁻⁸), of which 872 high-confidence single nucleotide polymorphisms (SNPs) were retained after quality control. Notably, 78% of these variants were located in non-coding regions, suggesting a strong regulatory role. Transcriptomic analysis revealed 2,156 differentially expressed genes (FDR < 0.05), including 1,204 upregulated and 952 downregulated genes. Expression quantitative trait loci (eQTL) analysis identified 1,032 significant variant–gene associations, with 72% classified as cis-eQTLs. Integration of eQTL and gene expression data highlighted 418 genes with both genetic and transcriptional evidence. Epigenomic profiling further identified 1,487 differentially methylated regions and 2,104 differentially accessible chromatin regions, indicating widespread regulatory alterations. Network analysis constructed a protein–protein interaction network comprising 1,126 nodes and 4,382 edges, identifying 87 hub genes central to disease mechanisms. Pathway enrichment analysis revealed 146 significantly associated pathways, with immune signaling (28%), apoptosis (23%), and cellular proliferation (20%) being the most prominent. Using machine learning approaches, 152 candidate genes were prioritized as potential therapeutic targets, with 25 high-confidence targets identified. Among these, 38% were classified as druggable, and 17% were associated with existing therapeutic compounds. Overall, this study demonstrates that integrative genomic analysis provides a robust framework for identifying functionally relevant variants and therapeutic targets, offering valuable insights into disease mechanisms and advancing precision medicine strategies.
Zitieren
APA
Hussain, S., Sabir, S., Tasleem, S., Mir, H., Afzal, W., Bukharai, N. T., Ikram, H., Khan, M. S., & Faheem, S. (2026). Integrative Genomic Analysis for the Identification of Disease-Associated Variants and Therapeutic Targets. Indus Journal of Bioscience Research, 4(3), 145-152. https://doi.org/10.70749/ijbr.v4i3.3036
Vancouver
Hussain S, Sabir S, Tasleem S, Mir H, Afzal W, Bukharai NT, et al. Integrative Genomic Analysis for the Identification of Disease-Associated Variants and Therapeutic Targets. Indus Journal of Bioscience Research. 2026;4(3):145-152. doi:10.70749/ijbr.v4i3.3036
BibTeX
@article{Hussain2026,
author = {Hussain, Sajid and Sabir, Sana and Tasleem, Samiyah and Mir, Huma and Afzal, Wajiha and Bukharai, Nain Tara and Ikram, Hira and Khan, Muhammad Saqib and Faheem, Seerat},
title = {Integrative Genomic Analysis for the Identification of Disease-Associated Variants and Therapeutic Targets},
journal = {Indus Journal of Bioscience Research},
year = {2026},
volume = {4},
number = {3},
pages = {145--152},
doi = {10.70749/ijbr.v4i3.3036}
}
EUVIMED